Orhan Tansel Korkmaz

Dr. Orhan Tansel Korkmaz

Department of Physiology
Faculty of Medicine
University of Eskisehir Osmangazi, Turkey
Assistant Professor



2008 Ph.D., University of Eskisehir Osmangazi, Medical Physiology

2004 B.S., University of Eskisehir Osmangazi, Biology

Publications (selected)

  1. Sener, E.; Korkmaz, OT; Yeniceli, D.; Dogrukol-Ak, D.; Tuncel, M.; Tuncel, N.; Determination of carbamazepine and its main metabolite carbamazepine-10, 11-epoxide in rat brain microdialysate and blood using ESI–LC–MS (Ion Trap), Chromatographia, 66: 31-36, 2007
  2. Tore, F.; Korkmaz, O.T.; Dogrukol-Ak, D.; Tunçel, N.; The Effects of Vasoactive Intestinal Peptide on Dura Mater Nitric Oxide Levels and Vessel-Contraction Responses in Sympathectomized Rats, Journal of molecular neuroscience, 41(2): 288-293, 2010
  3. Korkmaz, O.T.; Tunçel, N.; Tunçel, M.; Öncü, E.M.; Şahintürk, V.; Çelik, M.; Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells, Journal of molecular neuroscience, 41(2): 278-287, 2010
  4. Yeniceli, D.; Şener, E.; Korkmaz, O.T.; Doğrukol-Ak, D.; Tuncel, N.; A simple and sensitive LC–ESI-MS (ion trap) method for the determination of bupropion and its major metabolite, hydroxybupropion in rat plasma and brain microdialysates, Talanta, 84(1): 19-26, 2011
  5. Tunçel, N.; Korkmaz, O.T.; Tekin, N.; Şener, E.; Akyüz, F.; İnal, M.; Antioxidant and Anti-Apoptotic Activity of Vasoactive Intestinal Peptide (VIP) Against 6-Hydroxy Dopamine Toxicity in the Rat Corpus Striatum, Journal of Molecular Neuroscience, 2012
  6. Korkmaz, O.T.; Ay, H.; Ulupınar, E.; Tunçel, N.; Vasoactive Intestinal Peptide Enhances Striatal Plasticity and Prevents Dopaminergic Cell Loss in Parkinsonian Rats, Journal of Molecular Neuroscience, (Online) 2012

Profile Details

Last Updated: 2015-07-30